Levothyroxine

This MedLibrary.org supplementary page on Levothyroxine is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Levothyroxine
Systematic (IUPAC) name
3,5,3',5'-Tetraiodo-L-thyronine
Identifiers
CAS number 51-48-9
ATC code H03AA01
PubChem 853
DrugBank APRD00235
Chemical data
Formula C15H10I4NNaO4 
Mol. mass 798.86 (anhydrous)
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability ~100%
Metabolism Mainly in liver, kidneys, brain and muscles
Half life ca. 7 days (in hyperthyroidism 3-4 days, in hypothyroidism 9-10 days)
Excretion Through feces and urine
Therapeutic considerations
Pregnancy cat.

A(US)

Legal status

Prescription only

Routes Oral, Intravenous

Levothyroxine, also known as L-thyroxine, synthetic T4, or 3,5,3',5'-tetraiodo-L-thyronine, is a synthetic form of thyroxine (thyroid hormone). The natural hormone is chemically in the L-form, as is the pharmaceutical agent. Dextrothyroxine (D-thyroxine) briefly saw research as an anticholesterol agent but was pulled due to cardiac side-effects.

The EU has recently standardized on the use of the International Nonproprietary Name "levothyroxine" for the drug. Common brand names include "Thyrax", "Euthyrox", "Levaxin", "L-thyroxine" and "Eltroxin" in Europe, and "Levoxyl" and "Synthroid" in the United States. There are also numerous generic versions approved by the Food and Drug Administration.

Contents

Uses

This medicine is a hormone replacement usually given to patients with thyroid problems, specifically, hypothyroidism.[1] It is also given to people who have goitre or an enlarged thyroid gland.

Administration

It is recommended that levothyroxine be taken with an empty stomach approximately half an hour to an hour before meals to maximize its absorption. It is also recommended that the patient take the tablet with one glass of water to ease swallowing as well as to help the tablet dissolve for absorption.

Calcium and iron supplements (taken as a supplement with or without multivitamins) are known to suppress the absorption of levothyroxine and should be taken with a gap of at least four hours[2]. It is likely that zinc and magnesium would similarly affect absorption. Patients that started levothyroxine while taking calcium supplements may require re-titration of the levothyroxine.

Dosage, precautions and side effects

Dosages vary according the age groups and the individual condition of the patient, body weight and compliance to the medication and diet. Maximum dosage may reach 400 mcg per day but that is rare. Monitoring of the patients condition and adjustment of the dosage is periodical and necessary.

There are also foods and other substances that can interfere with absorption of thyroxine replacement. Avoid taking calcium and iron supplements within 4 hours of the medication and avoid taking soy products within 3 hours of the medication as these can reduce absorption of the medication. Other substances that reduce absorption are aluminium and magnesium containing antacids, simethicone or sucralfate, Cholestyramine, colestipol, Kayexalate. Other substances cause other adverse effects that may be severe. Ketamine may cause hypertension and tachycardia and Tricyclic and tetracyclic antidepressants increase its toxicity.On the other hand Lithium causes hyperthyroidism by affecting iodine metabolism of the thyroid itself and thus inhibits Synthetic levothyroxine as well.

Synthetic levothyroxine may have adverse side effects like: palpitations, nervousness, headache, difficulty sleeping, insomnia, swelling of the legs and ankles, weight loss and/or increased appetite. Allergies to the medicine are unlikely, but if the patient develops a severe reaction to this drug such as difficulty breathing, shortness of breath or swelling of the face and tongue it is imperative that the patient immediately seek medical attention.

Acute overdose may cause fever, hypoglycemia, heart failure, coma and unrecognized adrenal insufficiency. Acute massive overdose may be life-threatening; treatment should be symptomatic and supportive. Massive overdose may require beta-blockers for increased sympathomimetic activity.

Studies have shown that using liothyronine in combination with levothyroxine does not produce synergistic effects; other studies discourage the use of these two medications concurrently.

The side effects of overdosing appear 6 hours to 11 days after ingestion.

Marketing and approvals in the United States

Levothyroxine 25 µg tablets
Levothyroxine 25 µg tablets

Synthroid is the most prescribed brand of T4 in the United States. Synthroid was marketed in 1955, but was not FDA approved at that time as it was considered "generally regarded safe".[3] In the 1990s, in response to debate as to whether Synthroid was more effective than other levothyroxine preparations, (which ended up concluding that there was little difference between Synthroid and generic brands) all levothyroxine preparations were required to undergo the formal FDA approval process. Synthroid was approved by the FDA on 2002-07-24.[4]

Levothyroxine is on the negative formulary of several states, due the FDA's review of all l-thyroxine preparations in the 1990s. In the state of Florida for instance, Synthroid was only recently removed from the negative formulary, allowing pharmacies to dispense levothyroxine without prior physician approval.

References

  1. ^ BMJ 2008;337:a801
  2. ^ Ruth H. Michel, Patricia J. Neafsey, Laura Cox Dzurec: Self Medication Practices among Patients taking Levothyroxine. The Internet Journal of Advanced Nursing Practice. 2004. Volume 6 Number 2
  3. ^ "Abbott Laboratories Asks Federal Court to Help Protect Patients Against Misleading Information About Synthroid(R) (levothyroxine sodium, USP)". www.companyreports.com. Retrieved on 2008-08-14.
  4. ^ "Drugs@FDA". www.accessdata.fda.gov. Retrieved on 2008-08-14.

External links


Wikipedia content modification information:

  • This page was last modified on 14 August 2008, at 06:46.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Levothyroxine".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.